Can axillary lymph node dissection be omitted in breast cancer patients with metastatic sentinel lymph nodes undergoing mastectomy? A systematic review and meta …
F Chen, X Li, X Lin, L Chen, Z Lin, H Wu… - World Journal of Surgery, 2023 - Springer
Background The omission of axillary lymph node dissection (ALND) in patients with breast
cancer who have metastatic sentinel lymph nodes (SLNs) undergoing mastectomy remains …
cancer who have metastatic sentinel lymph nodes (SLNs) undergoing mastectomy remains …
Development of a prediction model based on LASSO regression to evaluate the risk of non-sentinel lymph node metastasis in Chinese breast cancer patients with 1–2 …
L Meng, T Zheng, Y Wang, Z Li, Q Xiao, J He, J Tan - Scientific Reports, 2021 - nature.com
This study aimed to develop an intraoperative prediction model to evaluate the risk of non-
sentinel lymph node (NSLN) metastasis in Chinese breast cancer patients with 1–2 positive …
sentinel lymph node (NSLN) metastasis in Chinese breast cancer patients with 1–2 positive …
A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1–2 breast cancer with only one sentinel lymph node …
L Liu, Y Lin, G Li, L Zhang, X Zhang, J Wu… - Frontiers in …, 2022 - frontiersin.org
Background T1–2 breast cancer patients with only one sentinel lymph node (SLN)
metastasis have an extremely low non-SLN (NSLN) metastatic rate and are favorable for …
metastasis have an extremely low non-SLN (NSLN) metastatic rate and are favorable for …
Non-sentinel lymph node metastases risk factors in patients with breast cancer with one or two sentinel lymph node macro-metastases
L Xu, J Zhao, X Wang, X Jin, B Wang, Y Fan, X Pei - Heliyon, 2023 - cell.com
Approximately 59% of patients with breast cancer with one or two sentinel lymph nodes (1–2
SLN) macrometastases do not benefit from axillary lymph node dissection (ALND), which …
SLN) macrometastases do not benefit from axillary lymph node dissection (ALND), which …
Management of the Axilla in T1-2 breast cancer patients with macrometastatic sentinel node involvement who underwent breast-conserving therapy
Purpose: The aims of our study were to determine the incidence of axillary recurrence and
arm morbidity in T1-2 invasive breast cancer patients with macrometastases on the sentinel …
arm morbidity in T1-2 invasive breast cancer patients with macrometastases on the sentinel …
[PDF][PDF] Factors predicting non-sentinel lymph node status in breast cancer patients with 1-2 macrometastatic positive sentinel lymph nodes
B Dong, Q Li, M Zhang, W Wu, Y Yao - Int J Clin Exp Med, 2018 - e-century.us
The aim of this study was to investigate predicting factors and to develop a predictive
nomogram for nonsentinel lymph nodes (non-SLNs) metastases in breast cancer patients …
nomogram for nonsentinel lymph nodes (non-SLNs) metastases in breast cancer patients …
[引用][C] Vaizdo tyrimų diagnostinė vertė krūties vėžio metastazėms pažasties limfmazgiuose nustatyti
D Rukanskienė - 2020 - Lietuvos sveikatos mokslų …